Lior Sagi

Summary

Publications

  1. ncbi Pancreatic panniculitis and carcinoma of the pancreas
    L Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 34:e205-7. 2009
  2. ncbi Silicone breast implant rupture presenting as bilateral leg nodules
    L Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 34:e99-101. 2009
  3. ncbi The role of therapeutic plasma exchange in pemphigus vulgaris
    L Sagi
    Department of Dermatology, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Eur Acad Dermatol Venereol 25:82-6. 2011
  4. ncbi Therapeutic hotline. Alefacept in the treatment of hyperkeratotic palmoplantar psoriasis
    Sagi Lior
    Dermatology Day Care and Phototherapy Center, Sheba Medical Center, Tel Hashomer and Dermatology Clinic, Tel Nordau Medical Center, Tel Aviv, Israel
    Dermatol Ther 23:556-60. 2010
  5. ncbi The Koebner phenomenon
    Lior Sagi
    Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
    Clin Dermatol 29:231-6. 2011
  6. ncbi Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria
    Lior Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Acta Derm Venereol 91:303-6. 2011
  7. ncbi [Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders]
    Alina Lozinski
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Ramat Gan
    Harefuah 151:562-5, 606. 2012
  8. ncbi Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature
    Lior Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Autoimmun Rev 10:527-35. 2011
  9. ncbi Pemphigus and infectious agents
    Lior Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Autoimmun Rev 8:33-5. 2008

Collaborators

Detail Information

Publications9

  1. ncbi Pancreatic panniculitis and carcinoma of the pancreas
    L Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 34:e205-7. 2009
    ..The patient was treated with nonsteroidal anti-inflammatory drugs, dexamethasone and antibiotics, with resolution of the dermatological symptoms...
  2. ncbi Silicone breast implant rupture presenting as bilateral leg nodules
    L Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 34:e99-101. 2009
    ..We discuss the common presentation of silicone migration and highlight the importance of awareness among dermatologists and plastic surgeons about this unusual occurrence...
  3. ncbi The role of therapeutic plasma exchange in pemphigus vulgaris
    L Sagi
    Department of Dermatology, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Eur Acad Dermatol Venereol 25:82-6. 2011
    ....
  4. ncbi Therapeutic hotline. Alefacept in the treatment of hyperkeratotic palmoplantar psoriasis
    Sagi Lior
    Dermatology Day Care and Phototherapy Center, Sheba Medical Center, Tel Hashomer and Dermatology Clinic, Tel Nordau Medical Center, Tel Aviv, Israel
    Dermatol Ther 23:556-60. 2010
    ..Alefacept should be considered as a therapeutic option for plaque-type PPP...
  5. ncbi The Koebner phenomenon
    Lior Sagi
    Department of Dermatology, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
    Clin Dermatol 29:231-6. 2011
    ..This contribution reviews the clinical manifestations of Koebner phenomenon, its provocative factors, suggested pathogenesis mechanisms, and the various skin conditions that exhibit this unique response...
  6. ncbi Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria
    Lior Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Acta Derm Venereol 91:303-6. 2011
    ..No serious adverse effects were reported. Methotrexate is an effective and safe treatment for chronic urticaria in patients who are not responsive to conventional therapy...
  7. ncbi [Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders]
    Alina Lozinski
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Ramat Gan
    Harefuah 151:562-5, 606. 2012
    ..This is one of the first reports of this kind of treatment for these rare life-threatening diseases. These case reports emphasize the role of Rituximab as a crisis therapy in autoimmune blistering diseases...
  8. ncbi Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature
    Lior Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Autoimmun Rev 10:527-35. 2011
    ..Among them, we found a novel association between H. pylori and ABD. Our study suggests a contributing role for HBV, HCV, H. pylori, T. gondii and CMV in inducing ABD in the genetically susceptible host...
  9. ncbi Pemphigus and infectious agents
    Lior Sagi
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Autoimmun Rev 8:33-5. 2008
    ..In this article we review the literature concerning the relationship between pemphigus, viral and bacterial pathogens...